Trials / Completed
CompletedNCT00385905
Excel Drug-Eluting Stent Pilot Clinical Registry
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- JW Medical Systems Ltd · Industry
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
The Trial aims to evaluate long-term efficiency of Excel stent in the inhibition of restenosis as well as the safety after the cessation of the 6-month anti-platelet drug treatment.
Detailed description
30-day, 6-month, and 12-month clinical follow-up and 6 to 9-month IVUS or SCA follow-up to measure long-term efficiency of Excel stent in the inhibition of restenosis as well as the safety after the cessation of the 6-month anti-platelet drug treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Excel Drug-eluting stent |
Timeline
- Start date
- 2006-02-01
- Completion
- 2007-01-01
- First posted
- 2006-10-11
- Last updated
- 2006-10-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00385905. Inclusion in this directory is not an endorsement.